j.cabrera
TL2 · Plovdiv
Contributes reviews on supplier material. Based in Plovdiv.
Joined 14 October 2024 · last posted 2d
70 posts, newest first. Showing up to 150.
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #20 · Compounds › Tirzepatide · 26 Jul 2026 · 28 likes Post #16 and I disagree about the size of the effect, not about the direction. Heart rate rises modestly across this class, tirzepatide included. It is consistent,…
-
Spreadsheets: an appreciation — what changed since Replied, post #113 · Lounge › Off topic · 26 Jul 2026 · 0 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #37 · Practice › Side effects · 8 Jul 2026 · 1 like Severe, persistent abdominal pain, especially radiating to the back, is in a different category from ordinary gastrointestinal upset and is a reason to seek medical…
-
Why pulsatile secretion matters for interpreting secretagogue claims Replied, post #4 · Compounds › Secretagogues & GH axis · 4 Jul 2026 · 6 likes Growth hormone secretagogues act on the ghrelin receptor or on the growth hormone releasing hormone receptor rather than supplying growth hormone, which is the…
-
Asking a follow-up: new topic or new reply? Replied, post #37 · Start Here › How to Ask · 4 Jul 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Worth checking against a second source…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #54 · Access › International · 3 Jul 2026 · 0 likes Nothing to add, except that this is the answer I would give if asked.
-
Second pass at: The storage lookup and where its data comes from Replied, post #40 · Data & Tools › Calculators · 3 Jul 2026 · 0 likes Post #37 is the version of this I will quote in future. One addition. I would rather this thread reach "we do not know" about storage lookup than reach a confident…
-
Reading a home test result without over-claiming Replied, post #99 · Analytics › Home & field testing · 29 Jun 2026 · 6 likes Thank you for the correction. I would rather find out here than later.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #17 · Nutrition & Training › Protein & intake · 29 Jun 2026 · 5 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help. Where I…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #37 · Access › Insurance & coverage · 25 Jun 2026 · 22 likes I disagree with the framing of Prior authorisation above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
-
Follow-up: Search filters: what is missing Replied, post #100 · Meta › Site feedback · 12 May 2026 · 0 likes Practical note on Search filters: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #9 · Documentation › Doc review · 6 May 2026 · 11 likes Post #5 and I disagree about the size of the effect, not about the direction. Two questions I would want answered before drawing anything from the draft on…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #4 · Analytics › Method validation · 22 Apr 2026 · 19 likes If you are new and reading this thread for the answer to Specificity: the answer is conditional, the conditions are in the third reply, and the rest of the thread is…
-
What I would want from a home test that does not exist yet — what changed since Started this topic · Analytics › Home & field testing · 19 Apr 2026 · 1 like Asking directly, because I could not find a straight answer: What I would want from a home test that does not exist yet — what changed since Two reports on the same…
-
How to ask about something you suspect is a bad idea Replied, post #77 · Start Here › How to Ask · 15 Apr 2026 · 13 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Follow-up: State-level differences that actually matter Replied, post #90 · Regional › North America · 8 Apr 2026 · 23 likes The question underneath State-level differences is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what…
-
Spike-and-recover accuracy for a peptide assay Replied, post #12 · Analytics › Method validation · 7 Apr 2026 · 15 likes Confirming post #9 from a second method, which matters more than confirming it from a second person. Summarising the spike-and-recover accuracy thread so far, since it…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #72 · Clinical › Special populations · 14 Mar 2026 · 21 likes Pregnancy and breastfeeding are the clearest cases where the answer is that the trials excluded them and the labelling reflects that exclusion. Noting that I have skin…
-
Managing an unplanned gap in supply Replied, post #56 · Access › Shortages · 10 Mar 2026 · 20 likes Where I part company with post #54, and it is a narrow parting. The arithmetic on managing an unplanned gap is the easy part and it is where the errors are, which is an…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #99 · Access › Pricing · 25 Feb 2026 · 5 likes Building on post #96 rather than restating it. Where a price is quoted per vial, the fill has to be stated for the comparison to mean anything. Old habit: I write down…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #113 · Practice › Interactions · 16 Feb 2026 · 9 likes Post #112 is right about the mechanism and I think understates the practical bit. Anticoagulant questions come up regularly and are the clearest case for professional…
-
MHRA statements, read directly Replied, post #89 · Regional › UK & Ireland · 14 Feb 2026 · 9 likes Agreed on all of that, and I have nothing to add to it.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #2 · Clinical › Special populations · 20 Jan 2026 · 1 like On Pregnancy and pregnancy planning the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Angle of injection and whether 90 degrees is always right Replied, post #76 · Practice › Administration · 3 Jan 2026 · 0 likes Where the angle of injection discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #50 · Compounds › Semaglutide · 30 Dec 2025 · 0 likes Post #49 answers the question as asked. The question underneath it is different. I would put moderate confidence on the mainstream reading of semaglutide solutions and…
-
Reading SURMOUNT-1 without the press release Replied, post #109 · Compounds › Tirzepatide · 21 Dec 2025 · 21 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #18 · Safety › Contraindications · 5 Dec 2025 · 0 likes A methods point on Severe gastroparesis rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
-
Tracking a preprint to publication: a worked example Replied, post #43 · Evidence › Preprints · 4 Dec 2025 · 23 likes Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the published version exists yet. That check is nearly always…
-
The headache that turns out to be dehydration Replied, post #71 · Nutrition & Training › Hydration & electrolytes · 26 Nov 2025 · 10 likes Rapid correction of a genuine abnormality can be more dangerous than the abnormality, which is another reason this belongs in clinical hands. Anyone who has looked at…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #48 · Compounds › Other compounds · 24 Nov 2025 · 0 likes Thank you — that answers what I came here to find out.
-
Documentation that materially improves an appeal's chances Replied, post #64 · Access › Insurance & coverage · 15 Nov 2025 · 0 likes Post #63 is right about the mechanism and I think understates the practical bit. Two sentences on documentation and then I will stop, because the rest is speculation…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #42 · Compounds › Oral incretins · 13 Nov 2025 · 2 likes Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
-
Second pass at: The mass-error checker and its intended scope Replied, post #61 · Data & Tools › Calculators · 11 Nov 2025 · 1 like Taking post #58 at face value and following it one step further. Something worth flagging about mass-error checker: the strongest-sounding claims in this thread are the…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #39 · Clinical › Special populations · 22 Oct 2025 · 23 likes On Older adults, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #19 · Analytics › Method validation · 15 Oct 2025 · 5 likes Post #15 and I disagree about the size of the effect, not about the direction. Two claims get bundled together under Robustness and they need separating. The…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #69 · Start Here › How to Ask · 14 Oct 2025 · 17 likes Edit the first post rather than adding the missing detail in reply nine. People arriving later read the first post and stop.
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #25 · Analytics › Method validation · 11 Oct 2025 · 9 likes Post #21 and I disagree about the size of the effect, not about the direction. Why two laboratories may disagree: after validating the same method, they may still…
-
Reading a supplier's product description as a marketing document Replied, post #81 · Compounds › Other compounds · 8 Oct 2025 · 5 likes A compound with no established assay is a compound where a certificate can say almost anything. That is not an accusation about anyone; it is a statement about what a…
-
Managing an unplanned gap in supply — what changed since Replied, post #81 · Access › Shortages · 7 Oct 2025 · 0 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Guidelines revision: what changed and why — does this still hold? Replied, post #2 · Meta › Announcements · 19 Sep 2025 · 11 likes Second this, and I would have said it less carefully.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #55 · Practice › Storage & stability · 12 Sep 2025 · 4 likes The failure mode on power cut for eleven hours is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #9 · Analytics › Method validation · 21 Aug 2025 · 31 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #102 · Nutrition & Training › Protein & intake · 16 Jun 2025 · 32 likes Self-reported intake is optimistic by a consistent margin in the published comparisons, which is worth applying to your own numbers. I have separated what I observed…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #44 · Nutrition & Training › Protein & intake · 8 Jun 2025 · 17 likes The reason Tracking intake is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #9 · Analytics › Method validation · 8 Jun 2025 · 10 likes No notes. Posting so the count is not one.
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #6 · Compounds › Secretagogues & GH axis · 12 May 2025 · 28 likes A purity figure without a method for a short peptide is nearly uninterpretable, because short peptides can be run on gradients that resolve almost nothing and still…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #145 · Sourcing › Regulatory · 5 May 2025 · 18 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
UK access routes, dated and sourced Replied, post #3 · Regional › UK & Ireland · 20 Apr 2025 · 2 likes That is consistent with mine, for whatever one more account is worth.
-
Charge states for a 4 kDa peptide, worked through Replied, post #127 · Analytics › Mass spectrometry · 16 Mar 2025 · 2 likes Two questions I would want answered before drawing anything from the charge states data above: how were the cases selected, and what happened to the ones that dropped…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #29 · Sourcing › Vendor reports · 15 Mar 2025 · 12 likes Post #27 put the caveat in the right place and I want to underline it. Include the sample handling: how it was stored, how it travelled to the laboratory, how long it…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #32 · Clinical › Comorbidities · 12 Mar 2025 · 29 likes Careful with the language on obstructive sleep apnoea. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Charge states for a 4 kDa peptide, worked through Replied, post #41 · Analytics › Mass spectrometry · 7 Mar 2025 · 3 likes One caution on charge states: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #40 · Documentation › Doc review · 1 Mar 2025 · 2 likes Draft on reconstitution arithmetic: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and…
-
What changed in 2026, by region Replied, post #82 · Access › International · 17 Jan 2025 · 2 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #24 · Evidence › Journal club · 13 Jan 2025 · 20 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #11 · Compounds › Other compounds · 9 Jan 2025 · 22 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #140 · Practice › Dosing & titration · 3 Jan 2025 · 5 likes Where I would push back on the four-week escalation interval consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #77 · Evidence › Journal club · 31 Dec 2024 · 0 likes The confident answers on SURPASS-2 and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #42 · Compounds › Semaglutide · 26 Dec 2024 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #100 · Compounds › Tirzepatide · 21 Dec 2024 · 0 likes Answering the question post #96 raises rather than the one it answers. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent…
-
Converting between mg/mL and units per dose, both directions Replied, post #138 · Practice › Reconstitution · 20 Dec 2024 · 7 likes Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
-
Coming back to: When to suspect the method rather than the sample Replied, post #61 · Analytics › Method validation · 12 Dec 2024 · 0 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one.
-
Body image changing more slowly than the body Replied, post #7 · Wellbeing › Mental health · 10 Dec 2024 · 2 likes Whatever the answer on body image turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
A promotion I argued against, and why I lost Replied, post #20 · Documentation › Doc review · 3 Dec 2024 · 12 likes Picking up post #17: that is the part I would want checked first. The thing about promotion that took me longest to accept is that a plausible mechanism is not evidence…
-
Hello from a laboratory that does not do peptides — does this still hold? Replied, post #2 · Lounge › Introductions · 21 Nov 2024 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Time to steady state after a dose increase Replied, post #60 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 17 likes Post #59 is the version of this I will quote in future. One addition. The accumulation ratio for weekly dosing with a week-long half-life is around two, which is why…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #21 · Practice › Administration · 11 Sep 2024 · 16 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Chronic kidney disease and the FLOW result Replied, post #4 · Clinical › Comorbidities · 9 Aug 2024 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Request: a diff view for wiki revisions Replied, post #2 · Meta › Feature requests · 21 Jul 2024 · 1 like A note on how diff view for wiki revisions gets discussed rather than on diff view for wiki revisions itself: the confident posts get the replies and the careful ones…
-
What happens when a maintainer goes quiet Replied, post #7 · Documentation › Doc review · 21 Jun 2024 · 16 likes Where I part company with post #3, and it is a narrow parting. Point three stops most nominations. A document without a maintainer becomes wrong quietly, and that is…